1847.70
2.93%
BOB Capital Markets Ltd.
Base domestic growth at 12% vs IMP growth of 8% due to new product launches and price increase
Eris Lifesciences Ltd. is trading above all available SMAs
More from Eris Lifesciences Ltd.
Recommended